These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9237447)

  • 1. Assessment of neurotoxicity from potential medications for drug abuse: ibogaine testing and brain imaging.
    Vocci FJ; London ED
    Ann N Y Acad Sci; 1997 May; 820():29-39; discussion 39-40. PubMed ID: 9237447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder.
    Barsuglia JP; Polanco M; Palmer R; Malcolm BJ; Kelmendi B; Calvey T
    Prog Brain Res; 2018; 242():121-158. PubMed ID: 30471678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.
    Corkery JM
    Prog Brain Res; 2018; 242():217-257. PubMed ID: 30471681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ibogaine medical subculture.
    Alper KR; Lotsof HS; Kaplan CD
    J Ethnopharmacol; 2008 Jan; 115(1):9-24. PubMed ID: 18029124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].
    Kazlauskas S; Kontrimaviciūte V; Sveikata A
    Medicina (Kaunas); 2004; 40(3):216-9. PubMed ID: 15064541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic literature review of clinical trials and therapeutic applications of ibogaine.
    Köck P; Froelich K; Walter M; Lang U; Dürsteler KM
    J Subst Abuse Treat; 2022 Jul; 138():108717. PubMed ID: 35012793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatalities temporally associated with the ingestion of ibogaine.
    Alper KR; Stajić M; Gill JR
    J Forensic Sci; 2012 Mar; 57(2):398-412. PubMed ID: 22268458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibogaine for treating drug dependence. What is a safe dose?
    Schep LJ; Slaughter RJ; Galea S; Newcombe D
    Drug Alcohol Depend; 2016 Sep; 166():1-5. PubMed ID: 27426011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High resolution brain SPECT imaging in a clinical substance abuse practice.
    Amen DG
    J Psychoactive Drugs; 2010 Jun; 42(2):153-60. PubMed ID: 20648911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating drug dependence with the aid of ibogaine: a retrospective study.
    Schenberg EE; de Castro Comis MA; Chaves BR; da Silveira DX
    J Psychopharmacol; 2014 Nov; 28(11):993-1000. PubMed ID: 25271214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences.
    Heink A; Katsikas S; Lange-Altman T
    J Psychoactive Drugs; 2017; 49(3):201-208. PubMed ID: 28266890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiological and neurological changes in the drug abuse patient: a study with MRI.
    Volkow ND; Valentine A; Kulkarni M
    J Neuroradiol; 1988; 15(3):288-93. PubMed ID: 3266757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Herbal seizures"--atypical symptoms after ibogaine intoxication: a case report.
    Breuer L; Kasper BS; Schwarze B; Gschossmann JM; Kornhuber J; Müller HH
    J Med Case Rep; 2015 Oct; 9():243. PubMed ID: 26518760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication development of ibogaine as a pharmacotherapy for drug dependence.
    Mash DC; Kovera CA; Buck BE; Norenberg MD; Shapshak P; Hearn WL; Sanchez-Ramos J
    Ann N Y Acad Sci; 1998 May; 844():274-92. PubMed ID: 9668685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel medications for drug addiction. The legacy of an African shrub.
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
    Popik P; Layer RT; Skolnick P
    Pharmacol Rev; 1995 Jun; 47(2):235-53. PubMed ID: 7568327
    [No Abstract]   [Full Text] [Related]  

  • 18. Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation.
    Onaivi ES; Ali SF; Chirwa SS; Zwiller J; Thiriet N; Akinshola BE; Ishiguro H
    Ann N Y Acad Sci; 2002 Jun; 965():28-46. PubMed ID: 12105083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
    de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
    Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mania following use of ibogaine: A case series.
    Marta CJ; Ryan WC; Kopelowicz A; Koek RJ
    Am J Addict; 2015 Apr; 24(3):203-205. PubMed ID: 25877487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.